Ann Dermatol.  2015 Oct;27(5):612-613. 10.5021/ad.2015.27.5.612.

Multiple Autoimmune Skin Manifestations in a Patient with Crohn's Disease Treated with a Tumor Necrosis Factor-Alpha Blocker

• Zattra E
• D'Inca R
• Bertollo G
• Tositti L
• Russo I
• Alaibac M

• KMID: 2171464
• DOI: http://doi.org/10.5021/ad.2015.27.5.612

Abstract

No abstract available.

MeSH Terms

Crohn Disease*
Humans
Skin Manifestations*
Skin*
Tumor Necrosis Factor-alpha*
Tumor Necrosis Factor-alpha

Figure

• 

  Fig. 1 (A) Circular areas of alopecia areata, (B) a circular, raised, 2~3-cm weal, surrounded by an inflammatory ring.

• 

  Fig. 2 (A) Multiple halo nevi on the back, (B) alopecia areata universalis.

Reference

1. Fabre C, Dereure O. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab. Dermatology. 2008; 216:185–186.

2. Wilson LH, Eliason MJ, Leiferman KM, Hull CM, Powell DL. Treatment of refractory chronic urticaria with tumor necrosis factor-alfa inhibitors. J Am Acad Dermatol. 2011; 64:1221–1222.

3. Mattox AR, Chappell JA, Hurley MY. New-onset vitiligo during long-term, stable infliximab treatment of pityriasis rubra pilaris. J Drugs Dermatol. 2013; 12:217–219.

4. Alghamdi KM, Khurrum H, Taieb A, Ezzedine K. Treatment of generalized vitiligo with anti-TNF-α Agents. J Drugs Dermatol. 2012; 11:534–539.